BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15660747)

  • 1. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 2. Calculation of coronary risk in Type II diabetes.
    Durrington P
    Clin Sci (Lond); 2001 Dec; 101(6):681-2. PubMed ID: 11724656
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
    Czech A; Szczeklik Z; Przybyś W
    Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
    Steiner G
    Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein (a): role in diabetes and its vascular complications.
    Mohan A; Srinivasan V; Deepa R; Mohan V
    J Assoc Physicians India; 2001 Nov; 49():1100-5. PubMed ID: 11868866
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary heart disease in type 2 diabetic patients: common and different risk factors in men and women.
    Lunetta M; Barbagallo A; Attardo T; Crimi S; Sangiorgio L
    Diabetes Metab; 1997 Jun; 23(3):230-1. PubMed ID: 9234001
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence suggests diabetes outcomes linked to homocysteine.
    Clement L
    Nephrol News Issues; 2003 Dec; 17(13):16-7. PubMed ID: 14694857
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors of macrovascular disease in diabetes mellitus.
    Jarrett RJ
    Horm Metab Res Suppl; 1985; 15():1-3. PubMed ID: 3865876
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes mellitus: a study utilizing the revised diagnostic criteria.
    de Andino RM; Mendoza M; Vera M; Martínez V
    Bol Asoc Med P R; 1988 Feb; 80(2):48-50. PubMed ID: 3348881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention].
    MMW Fortschr Med; 2006 Oct; 148(41):10-1. PubMed ID: 17190248
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
    Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
    Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 17. Restenosis in diabetic patients: is hyperinsulinemia the culprit?
    Aronson D
    Circulation; 1996 Dec; 94(11):3003-5. PubMed ID: 8941148
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose and coronary heart disease.
    Elkeles RS
    Eur Heart J; 2000 Nov; 21(21):1735-7. PubMed ID: 11052836
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower-extremity arterial calcification as a correlate of coronary artery calcification.
    Costacou T; Huskey ND; Edmundowicz D; Stolk R; Orchard TJ
    Metabolism; 2006 Dec; 55(12):1689-96. PubMed ID: 17142145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.